N-Acetyl Semax vs P21 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
N-Acetyl Semax is a modified form of Semax (the Russian-approved nootropic peptide based on ACTH(4-7)) with N-terminal acetylation added for improved enzymatic stability. The acetyl group protects against aminopeptidase degradation in nasal tissue, extending effective half-life a...
Calculate N-Acetyl Semax dose →P21 is a synthetic peptide derived from ciliary neurotrophic factor (CNTF), designed to promote neurogenesis - the formation of new neurons - in the hippocampus and olfactory bulb. CNTF is a potent neurotrophic factor but has poor CNS penetration and causes significant systemic s...
Calculate P21 dose →| Parameter | N-Acetyl Semax | P21 |
|---|---|---|
| Category | Cognitive & Neurological | Cognitive & Neurological |
| Research | Research Use | Preclinical |
| Half-Life | ~4–6 hours (extended vs. standard Semax) | - |
| Typical Dose | 100–400 µg | 100 µg/day |
| Frequency | Once or twice daily | Daily |
| Route | Intranasal | Subcutaneous / Intranasal |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.